ABROGATION OF THE HEMATOLOGICAL ACTIVITIES OF THE GM-CSF IL-3 FUSION PROTEIN (PIXY321) BY ANTI-PIXY321 ANTIBODIES IN CANCER-PATIENTS RECEIVING HIGH-DOSE CARBOPLATIN - RESULTS OF A PHASE-I STUDY/
Ll. Miller et al., ABROGATION OF THE HEMATOLOGICAL ACTIVITIES OF THE GM-CSF IL-3 FUSION PROTEIN (PIXY321) BY ANTI-PIXY321 ANTIBODIES IN CANCER-PATIENTS RECEIVING HIGH-DOSE CARBOPLATIN - RESULTS OF A PHASE-I STUDY/, Journal of clinical oncology, 14(5), 1996, pp. 2012-2012